罗恩 |
R029688-50mg |
50mg |
5~7个工作日 |
396129-53-6 |
LY364947 LY364947 |
98% |
3,197.00
3,197.00
|
|
罗恩 |
R029688-5mg |
5mg |
5~7个工作日 |
396129-53-6 |
LY364947 LY364947 |
98% |
457.00
457.00
|
|
罗恩 |
R029688-10mg |
10mg |
5~7个工作日 |
396129-53-6 |
LY364947 LY364947 |
98% |
733.00
733.00
|
|
TRC |
L486710-1mg |
1mg |
预期库存 |
396129-53-6 |
LY 364947 |
|
812.00
812.00
|
|
TRC |
L486710-5mg |
5mg |
预期库存 |
396129-53-6 |
LY 364947 |
|
1,134.00
1,134.00
|
|
TRC |
L486710-10mg |
10mg |
预期库存 |
396129-53-6 |
LY 364947 |
|
1,932.00
1,932.00
|
|
TRC |
L486710-25mg |
25mg |
预期库存 |
396129-53-6 |
LY 364947 |
|
3,948.00
3,948.00
|
|
TRC |
L486710-50mg |
50mg |
预期库存 |
396129-53-6 |
LY 364947 |
|
5,950.00
5,950.00
|
|
TRC |
L486710-250mg |
250mg |
预期库存 |
396129-53-6 |
LY 364947 |
|
22,904.00
22,904.00
|
|
毕得 |
BD136899-50mg |
50mg |
现货 |
396129-53-6 |
4-(3-吡啶-2-基-1H-吡唑-4-基)喹啉 4-(3-(Pyridin-2-yl)-1H-pyraz... |
98% |
293.00
293.00
|
|
毕得 |
BD136899-100mg |
100mg |
现货 |
396129-53-6 |
4-(3-吡啶-2-基-1H-吡唑-4-基)喹啉 4-(3-(Pyridin-2-yl)-1H-pyraz... |
98% |
498.00
498.00
|
|
毕得 |
BD136899-250mg |
250mg |
现货 |
396129-53-6 |
4-(3-吡啶-2-基-1H-吡唑-4-基)喹啉 4-(3-(Pyridin-2-yl)-1H-pyraz... |
98% |
599.00
599.00
|
|
阿拉丁 |
L129343-5mg |
5mg |
现货 |
396129-53-6 |
LY364947,TGFβR-I抑制剂 LY364947 |
≥98% |
380.90
380.90
|
|
阿拉丁 |
L129343-10mg |
10mg |
现货 |
396129-53-6 |
LY364947,TGFβR-I抑制剂 LY364947 |
≥98% |
610.90
610.90
|
|
阿拉丁 |
L129343-50mg |
50mg |
现货 |
396129-53-6 |
LY364947,TGFβR-I抑制剂 LY364947 |
≥98% |
2,663.90
2,663.90
|
|
阿拉丁 |
L423823-1ml |
1ml |
现货 |
396129-53-6 |
LY364947 LY364947 |
2mM in DMSO |
308.90
308.90
|
|